LOOKING FOR YOUR NEXT BUSINESS PARTNER
We provide business development consulting activity for European Pharma companies and investors looking for expansion opportunities in the MEA region and for Middle-East & African Pharma/Distributor companies looking for great partners or investors.
Partnering
We connect African and Middle-East companies with International partners or investors to boost their activities in the region.
Due Diligence
We work closely with our clients, using the breadth and depth of our consulting talent to undertake all aspects of due diligence.
Pharma Valuation
Our expert teams develop in-depth valuation models for our clients, helping inform strategic decision-making and investments.
NORALPHAR’s team of pharma business development consultants and advisors provide support to a broad range of clients, on both the buy side and sell side. We often supplement our client’s existing business development capabilities in-house, and selectively act as a client’s fully out-sourced business development team.
Much of our work is supporting pharma or OTC clients in preparation for, or during a transaction. We work with our pharma product development and commercialization colleagues to develop valuation models of an asset. Often, we are asked to help with message development and presentation optimization to ensure that an asset’s positioning resonates with buyers.
We have ongoing relationships with a number of companies who are looking to identify new assets to in-license or acquire, and have developed innovative approaches to identify new opportunities that are ‘under the radar’. Finally, we frequently support investors and companies with due diligence of pharmaceutical assets. We work with NORALPHAR’s extensive network of ex-industry expert consultants to undertake all aspects of technical, commercial and IP due diligence.
We deliver our findings in an easy to understand format enabling clients to clearly understand the principal areas of risk facing the asset or transaction.